ReviewJournal of inherited metabolic disease2021
Opportunities and challenges for antisense oligonucleotide therapies.
Elsa C Kuijper et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
83 papers cite itlatest 60 shown
this papertrialcites it